Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Dual role of microglia in health and disease: pushing the balance toward repair.
Erratum to: Cost Effectiveness of Oromucosal Cannabis-Based Medicine (Sativex(®)) for Spasticity in Multiple Sclerosis.
Intracellular Protein Shuttling: A Mechanism Relevant for Myelin Repair in Multiple Sclerosis?
EN FACE OPTICAL COHERENCE TOMOGRAPHY OF MACULAR MICROCYSTS DUE TO OPTIC NEUROPATHY FROM NEUROMYELITIS OPTICA.
Dietary Vitamin D and Its Metabolites Non-Genomically Stabilize the Endothelium.
Neocortical Neuronal Loss in Patients with Multiple System Atrophy: A Stereological Study.
Quantitative benefit-risk assessment of methylprednisolone in multiple sclerosis relapses.
The molecular physiology of the axo-myelinic synapse.
Eye and hand motor interactions with the Symbol Digit Modalities Test in early multiple sclerosis.
Paced auditory serial addition test: National normative data.
Ponesimod, a selective S1P1 receptor modulator: a potential treatment for multiple sclerosis and other immune-mediated diseases.
Bayesian scalar-on-image regression with application to association between intracranial DTI and cognitive outcomes.
A clinical conundrum: the detrimental effect of TNF antagonists in multiple sclerosis.
Bridging, switching or drug holidays - how to treat a patient who stops natalizumab?
Literature Commentary.
Not Lost in Translation: Emerging Clinical Importance of the G Protein-Coupled Estrogen Receptor GPER.
Vitamin D: A Narrative Review Examining the Evidence for Ten Beliefs.
Clinical and economic impact of five-year adherence to disease-modifying therapies in a commercially insured multiple sclerosis population.
Searching for the neural basis of reserve against memory decline: intellectual enrichment linked to larger hippocampal volume in multiple sclerosis.
Effectiveness of Group Versus Individual Yoga Exercises on Fatigue of Patients with Multiple Sclerosis.
Rapid worsening of IgM anti-MAG demyelinating polyneuropathy during rituximab treatment.
Longitudinally extensive transverse myelitis suspected for isolated Neuro-Behçet: A diagnostic conundrum.
Erratum to: Disentangling Multiple Sclerosis and depression: an adjusted depression screening score for patient-centered care.
What to make of cannabis and cognition in MS: In search of clarity amidst the haze.
Poor early relapse recovery affects onset of progressive disease course in multiple sclerosis.
Pages
« first
‹ previous
…
641
642
643
644
645
646
647
648
649
…
next ›
last »